Drugs / BNT165b1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05581641 | Dec 2022 → Feb 2024 | malaria | BioNTech SE | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT165b1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05581641 ↗ |
| Modality | Vaccine | “RNA vaccine for active immunization against malaria” NCT05581641 ↗ |
| Route | Intramuscular | “administered as intramuscular injection” NCT05581641 ↗ |